Combination therapy for the prophylaxis and/or treatment of beni

Details Combination therapy for the prophylaxis and/or treatment of beni Combination therapy for the prophylaxis and/or treatment of beni

1995-06-07

1998-10-06

Kishore, Gollamudi S.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514170, 514177, 514178, 514646, 514647, A61K 3156

Patent

active

058176497

ABSTRACT:
A combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia in susceptible warm-blooded animals which comprises administering a combination of two or more compounds selected from the group consisting of an inhibitor of 5.alpha.-reductase activity, an anti-estrogen, an inhibitor of aromatase activity, an inhibitor of 17.beta.-hydroxysteroid dehydrogenase activity and, in some cases, an anti-androgen and/or an LHRH agonist. Pharmaceutical compositions useful for such treatment and pharmaceutical kits containing such compositions are disclosed.

REFERENCES:
patent: 4039669 (1977-08-01), Beyler et al.
patent: 4087461 (1978-05-01), Robinson
patent: 4235893 (1980-11-01), Brodie et al.
patent: 4329364 (1982-05-01), Neri et al.
patent: 4472382 (1984-09-01), Labrie et al.
patent: 4474813 (1984-10-01), Neri et al.
patent: 4598072 (1986-07-01), Schweikert et al.
patent: 4659695 (1987-04-01), Labrie
patent: 4684635 (1987-08-01), Orentreich et al.
patent: 4732897 (1988-03-01), Cainelli et al.
patent: 4888336 (1989-12-01), Holt et al.
patent: 4895715 (1990-01-01), Neri et al.
patent: 5053403 (1991-10-01), Orentreich et al.
Anderson, et al., Nature, 219:277-279 (1968).
Andriole, et al., The Prostate, 10:189-197 (1987).
Andriole, et al., p. 123.
Batzold, Prostatic Cell, pp. 269-282 (1981).
Brogden, et al., Drugs, 38(2):185-203 (1989).
Brooks, et al., The Prostate, 9:65-75 (1986).
Bruchovsky, J. Clin. Endocrin. & Metab., 67(4):806-816 (1988).
Burger's Medicinal Chemistry, 4th Ed., Pt II, pp. 637-643.
Crawford, et al., N. Engl. J. Med., 321:419-424 (1989).
Feyel-Cabanes, et al., Steroid Receptors, Metabolism & Prostatic Cancer (1980).
Geller, et al., J. Clin. Endo. & Metab., 58:36-40 (1984).
Geller, et al., J. Urol., 132:693-696 (1984).
Halgunset, et al., J. Steroid Biochem., 28(6):731-736 (1987).
Hudson, J. Steroid Biochem., 26(3):349-363 (1987).
Isaacs, et al., The Prostate, pp. 33-40 (1989).
Ito, et al., J. Pharm. Pharmacol. , 41:488-489 (1989).
Kadohama, et al., JNCI, 74(2):475-486 (1985).
Labrie, et al., Proc. Nat'l Acad. Sci., 81:3861-3863 (1984).
Labrie, et al., The Prostate, 4:579-594 (1983).
Labrie, et al., J. Steroid. Biochem., 23(5B):833-841 (1985).
Labrie, et al., Important Advances in Oncology, pp. 193-217 (1985).
Liang, et al., Endocrinology, 117(2):571-579 (1985).
Liang, et al., J. Biol. Chem., 256(15):7998-8005 (1981).
Padilla, et al., The Prostrate, 6:129-143 (1985).
Padilla, et al., J. Steroid Biochem., 25(Suppl.)122S (1986).
Petrow, et al., Steroids, 38:121-140 (1981).
Petrow, et al., J. Pharm. Pharmacol., 36(5):352-353 (1984).
Petrow & Lack, Prostatic Cell, pp. 283-297 (1981).
Petrow, et al., J. Endocrinology, 95:311-313 (1982).
Petrow, The Prostate, 9:343-361 (1986).
Rasmussion, et al., J. Med. Chem., 27:1690-1701 (1984).
Raynaud, et al., Bull. Cancer, 73:36-46 (1986).
Sandberg & Kadohama, Progress in Cancer Res. and Therapy 31:477-489 (1984).
Stone, et al., The Prostate, 9:311-318 (1986).
Stoner, et al., Clin. Res., 35:402A (1987).
Vacurg, Sug. Gynecol. Obstet. 124:1011-1017 (1967).
Vermeulen, et al., The Prostate, 14:45-53 (1989).
Kozak, et al., The Prostate, 3:433, 438 (1982).
Griffith, et al., Perspectives I, 1-6 (1990).

Affiliated with

Also associated with

Rating

Combination therapy for the prophylaxis and/or treatment of beni does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for the prophylaxis and/or treatment of beni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for the prophylaxis and/or treatment of beni will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-77242